1Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia diagnosis, assessment of severity, antimicrobial therapy, and prevention [J]. Am J Respir Crit Care Med,2007; 163 (7): 1730-54.
2Salvatore CM, Fonseca-Aten M, Katz-Gaynor K, et al. Respiratory tract infection with Mycoplasrna pneuvaoniae in interleukin-12 knockout mice resuits in improved bacterial clearance and reduced pulmonary inflammation[J]. Infect Immun,2007 ;75( 1 ) :236-42.
3Capoor MR, Nair D, Srivastava L, et al. Characterization and changing minimum inhibitory concentration (MIC) of acinetobacter species from a tertiary care setup[J]. J Commun Dis,2005 ;37(2):99-107.
5Borzenko AS, Gagarina SG, Samoilova IV, et al. Primarydrug resistance in Mycobacterium tuberculosis among patients with pulmonary tuberculosis and its impact on permanent disability in the Volgograd region [J]. Probl Tuberk Bolezn Legk ,2007 ; 12( 1 ) :28-30.
6Blium NM, Ariel' BM, Bellendir EN, et al. Specific and nonspecific bron-chial and regional lymph nodal lesions as a manifestation of synergism in the lymph epithelial system in pulmonary tuberculosis [J]. Probl Tuberk Bolezn Legk,2008 ;12( 1 ) :8-12.
7Yoo SJ, Oh HJ, Shin BM. Evaluation of four commercial IgG- and IgM- specific enzyme immunoassays for detecting Mycoplasma pneumoniae antibody : comparison with particle agglutination assay [J]. J Korean Med Sci ,2007 ;22 ( 5 ) :795-801.
2Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia[J].N Engl J Med,1997,336:243-250.
3Skerrett SJ.Diagnostic testing for community-acquired pneumonia[J].Clin Chest Med,1999,20:531-548.
4Dean NC,Silver MP,Bateman KA,et al.Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia[J].Am J Med,2001,110:451-457.
5Niederman MS.Guidelines for the management of community-acquired pneumonia[J].Med Clin North Am,2001,85:1493-1501.
6Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia:diagnosis assessment of severity,antimicrobial therapy and prevention[J].Am J Respir Crit Care Med,2001,163:1730-1754.
7Ho PL,Yung RW,Tsang DN,et al.Increasing resistance of streptococcus pneumonia to fluroquinotones:results of a Hong Kong multicentre study in 2000[J].J Antimicrob Chemother,2001,48:659-665.
7Lee SW,Hong YS,Park DW,et al.Lactic acidosis not hyperlactatemia as a predictor of in hospital mortality in septic emergency patients[J].E-mergency Med J,2008;25(10):659-65.
8Elkind M S, Ramakrishnan P, Moon Y P, et al. Infectious burden and risk of stroke:the northen manhattan study [J]. Arch neurol, 2010, 67 (1): 33-38.
9Torkaman M, Afsharpaiman SH, Hoseini MJ, et al. Platelet count and neonatal sepsis:a high prevalenceofEnterobacter sppl [J]. Singapore Med J, 2009, 50(23): 482.
10Bari A, Sadruddin S, Khan A, et al. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial[J].Lancet, 2011, 378(9805): 1796-1803.
